science

Multisystem inflammatory syndrome in children

Multisystem inflammatory syndrome in children is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Multisystem inflammatory syndrome in children rather than just read about it. In short: Multisystem inflammatory syndrome in children (MIS-C), or paediatric inflammatory multisystem syndrome (PIMS / PIMS-TS), or systemic inflammatory syndrome in COVID-19 (SISCoV), is a rare systemic illness involving persistent fever and extreme inflammation following exposure to SARS-CoV-2, the virus responsible for COVID-19. Studies have suggested that MIS-C occurred in 31.6 out of 100,000 people under 21 who were in…

Key takeaways

Multisystem inflammatory syndrome in children belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Multisystem inflammatory syndrome in children to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Multisystem inflammatory syndrome in children from memory before moving on to harder problems.

Reference excerpt

Multisystem inflammatory syndrome in children (MIS-C), or paediatric inflammatory multisystem syndrome (PIMS / PIMS-TS), or systemic inflammatory syndrome in COVID-19 (SISCoV), is a rare systemic illness involving persistent fever and extreme inflammation following exposure to SARS-CoV-2, the virus responsible for COVID-19. Studies have suggested that MIS-C occurred in 31.6 out of 100,000 people under 21 who were infected with COVID-19. It can rapidly lead to medical emergencies such as insufficient blood flow around the body (a condition known as shock). Failure of one or more organs can occur. A warning sign is unexplained persistent fever with severe symptoms following exposure to COVID-19. Prompt referral to paediatric specialists is essential, and families need to seek urgent medical assistance. All affected children have persistent fever. Other clinical features vary. The first symptoms often include acute abdominal pain with diarrhea or vomiting. Muscle pain and general fatigue are frequent, and low blood pressure is also common. Symptoms can also include pink eye, rashes, enlarged lymph nodes, swollen hands and feet, and "strawberry tongue". Various mental disturbances are possible. A cytokine storm may take place, in which the child's innate immune system stages an excessive and uncontrolled inflammatory response. Heart failure is common. Clinical complications can include damage to the heart muscle, respiratory distress, acute kidney injury, and increased blood coagulation. Coronary artery abnormalities can develop (ranging from dilatation to aneurysms). As of 2020, the disease proved fatal in under 2% of reported cases. Early recognition and prompt specialist attention are essential. Anti-inflammatory treatments have been used, with good responses being recorded for intravenous immunoglobulin (IVIG), with or without corticosteroids. Oxygen is often needed, and supportive care is key for treating clinical complications. Mortality is low for children who receive expert hospital care. Knowledge of the syndrome evolved rapidly through the course of the COVID-19 pandemic (2020–2023). Its clinical features may appear somewhat similar to Kawasaki disease, a rare disease of unknown origin that typically affects young children, in which blood vessels become inflamed throughout the body.> It can also show features of other serious inflammatory conditions of childhood, including toxic shock and macrophage activation syndromes. This emerging condition has been defined slightly differently (using different names), by the World Health Organization (WHO), the Royal College of Paediatrics and Child Health (RCPCH) in the UK, and the Centers for Disease Control and Prevention (CDC) in the US. Although the condition is thought to follow SARS-CoV-2 viral infection, antigen or antibody tests are not always positive. Exclusion of alternative causes, including bacterial and other infections, is essential for differential diagnosis. Some general clinical guidance has been provided by the RCPCH, the National Institutes of Health, the American College of Rheumatology, and the American Academy of Pediatrics. Clusters of new cases have been reported two to six weeks after local peaks in viral transmission. The disease is thought to be driven by a delayed biological mechanism in certain predisposed children. In May 2020, the European Centre for Disease Prevention and Control (ECDC) rated risk to children in Europe as being "low" overall, based on a "very low" likelihood of a child developing this "high impact" disease. Regarding ethnicity, the condition seems to affect more children of African, Afro-Caribbean, and Hispanic descent, whereas Kawasaki disease affects more of East Asian ancestry. In adults, the condition is called multisystem inflammatory syndrome in adults (MIS-A) in the US. As of August 2026, in the Anglosphere, only the United States and Australia continue to publish an ongoing tally of cases. At this date, the CDC reports a total number of cases of MIS as 9,808, with 80 deaths recorded in the United States (population c. 350 million. In Australia (population c. 28 million), there have been 217 confirmed cases in total, the number peaking in 2022. Vaccination against COVID-19 is cconsidered the best defence against developing PIMS.

Name The disorder has been called by various names, including:

Multisystem inflammatory syndrome in children (MIS-C) Multisystem inflammatory syndrome (MIS) in children and adolescents temporally related to COVID-19 Paediatric inflammatory multisystem syndrome (PIMS) Paediatric inflammatory multisystem syndrome, temporally associated with SARS-CoV-2 infection (PIMS-TS) Paediatric multisystem inflammatory syndrome (PMIS) Kawa-COVID-19 Systemic inflammatory syndrome in COVID-19 (SISCoV)

Background

… excerpt ends here. Continue reading the full article.

Illustrations

Worked examples

Example 1 — a first encounter with Multisystem inflammatory syndrome in children

Start with the simplest possible case. Write down what Multisystem inflammatory syndrome in children claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Multisystem inflammatory syndrome in children before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Multisystem inflammatory syndrome in children ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Multisystem inflammatory syndrome in children

In research: Multisystem inflammatory syndrome in children appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Multisystem inflammatory syndrome in children in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Multisystem inflammatory syndrome in children is common in secondary-school and first-year university syllabi. It links to neighbouring topics Ailments of unknown cause, Impact of the COVID-19 pandemic on other health issues, Inflammations, so understanding it makes those chapters shorter.
In everyday life: Look for Multisystem inflammatory syndrome in children outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Multisystem inflammatory syndrome in children” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Multisystem inflammatory syndrome in children in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Multisystem inflammatory syndrome in children means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Multisystem inflammatory syndrome in children out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Multisystem inflammatory syndrome in children in simple terms?

Why does Multisystem inflammatory syndrome in children matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Multisystem inflammatory syndrome in children?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Multisystem inflammatory syndrome in children.